DarioHealth (NSDQ:DRIO) said today that it launched its smart diabetes platform in Germany – the ninth country in which the Israel-based company’s technology is commercially available.
DarioHealth’s platform includes a blood glucose monitoring system, which connects via a headphone jack to a mobile device.
The system also includes a lancing device and test strips, together with the meter, to help diabetes patients monitor their blood glucose throughout the day. There is no carrying case or batteries, according to DarioHealth, and users can access real-time and historical blood glucose data to watch out for trends.
Nearly 10% of the 82 million people in Germany are living with diabetes, the company reported.
“Our technology can help guide consumers to analyze and personalize their diabetes treatment in effort to increase better clinical outcomes,” chairman & CEO Erez Raphael said in prepared remarks. “We’ve received tremendous positive feedback about the Dario smart diabetes solution and we look forward to providing the German market with an unrivaled method for self-diabetes management.
“From a business perspective, this is a very big achievement for us. We’ve successfully expanded our international market presence, allowing us to capitalize on the most cost-effective markets as we bring personalized healthcare management to diabetes and pre-diabetes patients around the world.”
